1. Home
  2. MCB vs CADL Comparison

MCB vs CADL Comparison

Compare MCB & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

BUY

Current Price

$87.50

Market Cap

1.2B

Sector

Finance

ML Signal

BUY

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$9.73

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
CADL
Founded
1999
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MCB
CADL
Price
$87.50
$9.73
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
★ $105.33
$21.75
AVG Volume (30 Days)
99.7K
★ 1.1M
Earning Date
10-20-2026
11-12-2026
Dividend Yield
★ 1.58%
N/A
EPS Growth
11.64
★ 58.62
EPS
★ 4.40
N/A
Revenue
★ $11,053,000.00
$125,000.00
Revenue This Year
$20.34
N/A
Revenue Next Year
$13.88
N/A
P/E Ratio
$20.15
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$64.66
$4.35
52 Week High
$102.04
$14.00

Technical Indicators

Market Signals
Indicator
MCB
CADL
Relative Strength Index (RSI) 38.04 35.54
Support Level $86.55 $9.18
Resistance Level $93.55 $10.59
Average True Range (ATR) 1.86 0.65
MACD -0.01 -0.17
Stochastic Oscillator 32.17 7.48

Price Performance

Historical Comparison
MCB
CADL

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: